Targeted therapy: Leveraging ADCC to enhance anti-HER2 therapy.

Targeted therapy: Leveraging ADCC to enhance anti-HER2 therapy.

Nat Rev Clin Oncol. 2017 Feb 14;:

Authors: Killock D

PMID: 28195234 [PubMed - as supplied by publisher]

http://ift.tt/2lj4iVl